LORATADINE TEVA CONSEIL 10 mg, tablet 7 tablets
Active ingredients: Loratadine
Commercialized according to BDPM
Tablet7 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LORATADINE TEVA CONSEIL 10 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) transparente(s) PVC PVDC aluminium de 7 comprimé(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Jun 2010
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62367569CIP73828337CIP133400938283372Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LORATADINEcomprimé | 10 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.